Literature DB >> 21857844

Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection.

D Ogoina1, G Onyemelukwe, B O Musa, A Babadoko.   

Abstract

BACKGROUND: There is a dearth of studies on HHV8-HIV co-infections from Nigeria, even as both infections have been shown to be endemic in Africa. This study examined the seroprevalence and determinants of HHV8 infections in adult Nigerians with and without HIV-infection.
METHODS: In 2007, a cross sectional study undertaken in a tertiary hospital in Zaria, northern Nigeria enrolled 71 HIV-1 positive adults without Kaposi's sarcoma and 85 apparently healthy HIV-negative adult volunteers of the general population. Anti-lytic antibodies to HHV8 infection was determined by ELISA. A univariate analysis including age, sex, marital status, past sexually transmitted disease (STD), past blood transfusion, HIV/AIDS staging and CD4 count was used to determine variables associated with HHV8 seropositivity. Significant variables were adjusted in a logistic regression model expressed in odds ratio (OR) with 95% confidence interval (CI). P<0.05 was considered significant
RESULTS: The seroprevalence of HHV8 infection was 62% in HIV-1 positive patients and 25.9% in HIV negative adults (p<0.001). A past history of STD [OR= 2.88, 95% CI= 1.0 - 8.2] and advanced HIV/AIDS (WHO stage 3 and 4) [OR=3.5, 95% CI= 1.21-10.1] were the only variables independently associated with HHV8 seropositivity in HIV-infected patients. In HIV-negative adults, none of the variables was significantly associated with HHV8 seropositivity.
CONCLUSION: The study findings suggest an adverse interaction between HHV8 and HIV-1. The higher prevalence of HHV8 infection in HIV-infected patients and its association with STD support a predominant sexual route of HHV8 transmission among adult Nigerians.

Entities:  

Keywords:  HHV8; HIV-1; KS; Nigeria; STD; Seroprevalence

Mesh:

Year:  2011        PMID: 21857844      PMCID: PMC3158522     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  15 in total

1.  Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria.

Authors:  Mohamed A Eltom; Sam M Mbulaiteye; Abinbola J Dada; Denise Whitby; Robert J Biggar
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

2.  Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR.

Authors:  Elisabetta Caselli; Paola Menegazzi; Arianna Bracci; Monica Galvan; Enzo Cassai; Dario Di Luca
Journal:  J Gen Virol       Date:  2001-08       Impact factor: 3.891

Review 3.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.

Authors:  T F Schulz
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

4.  Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors.

Authors:  Wolfgang Hladik; Sheila C Dollard; Robert G Downing; Peter Kataaha; Philip E Pellett; John M Karon; Jonathan Mermin; Eve M Lackritz
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

Review 5.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

6.  Human herpesvirus 8 infection within families in rural Tanzania.

Authors:  Sam M Mbulaiteye; Ruth M Pfeiffer; Denise Whitby; Glen R Brubaker; John Shao; Robert J Biggar
Journal:  J Infect Dis       Date:  2003-06-01       Impact factor: 5.226

7.  Seroprevalence of HHV 8 antibodies among the general population and HIV positive persons in the Czech Republic.

Authors:  A Suchánková; M Stanková; K Roubalová; J Vandasová; M Brůcková
Journal:  J Clin Virol       Date:  2003-09       Impact factor: 3.168

Review 8.  Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.

Authors:  Ulrich R Hengge; Thomas Ruzicka; Stephen K Tyring; Martin Stuschke; Michael Roggendorf; Robert A Schwartz; Siegfried Seeber
Journal:  Lancet Infect Dis       Date:  2002-05       Impact factor: 25.071

9.  Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.

Authors:  Andrew A Adjei; Henry B Armah; Foster Gbagbo; Isaac Boamah; Clement Adu-Gyamfi; Isaac Asare
Journal:  BMC Infect Dis       Date:  2008-08-18       Impact factor: 3.090

Review 10.  Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma.

Authors:  M Dedicoat; R Newton
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more
  9 in total

1.  Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Authors:  Sara Gianella; Sheldon R Morris; Christy Anderson; Celsa A Spina; Milenka V Vargas; Jason A Young; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

2.  Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).

Authors:  Lia Koski; Twalib Ngoma; Julius Mwaiselage; Lynne Le; Amr S Soliman
Journal:  Int J STD AIDS       Date:  2014-07-30       Impact factor: 1.359

3.  Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon.

Authors:  Christelle Mbondji-Wonje; Viswanath Ragupathy; Sherwin Lee; Owen Wood; Bih Awazi; Indira K Hewlett
Journal:  Viruses       Date:  2013-09-19       Impact factor: 5.048

4.  Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria.

Authors:  Dimie Ogoina; Reginald O Obiako; Haruna M Muktar; Mukhtar Adeiza; Aliyu Babadoko; Abdulaziz Hassan; Isa Bansi; Henry Iheonye; Matthew Iyanda; Eric Tabi-Ajayi
Journal:  AIDS Res Treat       Date:  2012-09-17

5.  [Seroprevalence of human herpes virus-8 in HIV-positive patients at the General Hospital of Yaounde - Cameroon].

Authors:  Njiki Bikoï Jacky; Ndom Paul; Mupang Lilian; Agokeng Demanou Sylvie
Journal:  Pan Afr Med J       Date:  2015-01-26

Review 6.  HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998⁻2017: A Systematic Review.

Authors:  Elizabeth M Etta; Doyinmola P Alayande; Lufuno G Mavhandu-Ramarumo; George Gachara; Pascal O Bessong
Journal:  Viruses       Date:  2018-08-27       Impact factor: 5.048

7.  Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006-2017.

Authors:  Maxwell O Akanbi; Lucy A Bilaver; Chad Achenbach; Lisa R Hirschhorn; Adovich S Rivera; Olugbenga A Silas; Patricia A Agaba; Oche Agbaji; Nathan Y Shehu; Solomon A Sagay; Lifang Hou; Robert L Murphy
Journal:  Infect Agent Cancer       Date:  2022-03-21       Impact factor: 2.965

8.  DETECTION OF HUMAN HERPESVIRUS-8 ANTIGEN IN HIV-INFECTED PATIENTS IN EAST JAVA, INDONESIA.

Authors:  Devi Oktafiani; Ni Luh Ayu Megasari; Elsa Fitriana; Maria Inge Lusida
Journal:  Afr J Infect Dis       Date:  2018-06-18

9.  Human herpes virus 8 antibodies in HIV-positive patients in Surabaya, Indonesia.

Authors:  Devi Oktafiani; Ni LuhAyu Megasari; Elsa Fitriana; Maria Inge Lusida
Journal:  Infect Dis Rep       Date:  2020-07-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.